TY - JOUR T1 - Randomized Re-Opening of Training Facilities during the COVID-19 pandemic JF - medRxiv DO - 10.1101/2020.06.24.20138768 SP - 2020.06.24.20138768 AU - The TRAiN study group AU - Lise M. Helsingen AU - Magnus Løberg AU - Erle Refsum AU - Dagrun Kyte Gjøstein AU - Paulina Wieszczy AU - Ørjan Olsvik AU - Frederik E. Juul AU - Ishita Barua AU - Henriette C. Jodal AU - Magnhild Herfindal AU - Yuichi Mori AU - Solveig Jore AU - Fridtjof Lund-Johansen AU - Atle Fretheim AU - Michael Bretthauer AU - Mette Kalager Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/24/2020.06.24.20138768.abstract N2 - Background Most countries closed training facilities during the COVID-19 pandemic. This may have negative consequences for people’s health and wellbeing. We investigated SARS-CoV-2 virus transmission and COVID-19 disease attributable to training facilities.Methods We randomized members 18 to 64 years with no COVID-19 relevant comorbidities randomized Five training facilities in Oslo, Norway to access or no access to their training facility. Facilities were opened from May 22, 2020 for individuals randomized to training, applying increased social distancing (1 meter for floor exercise, 2 meters for high-intensity classes), enhanced hand and surface hygiene. Locker rooms were open, showers and saunas were closed. We measured SARS-CoV-2 PCR status by self-administered naso-, oropharyngeal and sputum sampling after two weeks and clinical disease by linkage to electronic patient records after three weeks.Results 3,764 individuals were randomized and included in analyses; 1,896 in the training and 1,868 in no-training arms. In the training arm, 81.8% trained at least once at the facilities, and 38.5% trained ≥six times. Out of 3,016 individuals who returned the SARS-CoV-2 PCR tests (80.5%), there was one positive test. The positive individual was randomized to training, but had not used the facility before testing day. Contact tracing revealed the workplace as transmission source. A total of 106 individuals (2.8%) had outpatient hospital visits, and six individuals were admitted to hospital during the three weeks after intervention start, with no differences between arms. There were no outpatient visits or hospital admissions due to COVID-19 in either group.Conclusions Provided good hygiene and social distancing measures, there was no increased COVID-19 spread at training facilities. NCT04406909Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04406909Funding StatementNorwegian Research Council (grant no. 312757)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:South-East Norway IRB, Oslo, NorwayAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available on request in tabulated form. ER -